Literature DB >> 31768027

Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets.

Masaki Imai1, Makoto Yamashita2, Yuko Sakai-Tagawa2, Kiyoko Iwatsuki-Horimoto2, Maki Kiso2, Jurika Murakami2, Atsuhiro Yasuhara2, Kosuke Takada2, Mutsumi Ito2, Noriko Nakajima3, Kenta Takahashi3, Tiago J S Lopes2,4, Jayeeta Dutta5, Zenab Khan5, Divya Kriti5, Harm van Bakel5, Akifumi Tokita6,7, Haruhisa Hagiwara7,8, Naomi Izumida7,9, Haruo Kuroki10, Tamon Nishino7,11, Noriyuki Wada7,12, Michiko Koga13, Eisuke Adachi14, Daisuke Jubishi2,15, Hideki Hasegawa3,16, Yoshihiro Kawaoka17,18,19.   

Abstract

Here we report the isolation of the influenza A/H1N1 2009 pandemic (A/H1N1pdm) and A/H3N2 viruses carrying an I38T mutation in the polymerase acidic protein-a mutation that confers reduced susceptibility to baloxavir marboxil-from patients before and after treatment with baloxavir marboxil in Japan. These variants showed replicative abilities and pathogenicity that is similar to those of wild-type isolates in hamsters; they also transmitted efficiently between ferrets by respiratory droplets.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31768027     DOI: 10.1038/s41564-019-0609-0

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  29 in total

Review 1.  Baloxavir Marboxil: A Review in Acute Uncomplicated Influenza.

Authors:  Matt Shirley
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546

2.  Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonuclease.

Authors:  Dominga Rogolino; Lieve Naesens; Jennifer Bartoli; Mauro Carcelli; Laura De Luca; Giorgio Pelosi; Ryjul W Stokes; Ria Van Berwaer; Serena Vittorio; Annelies Stevaert; Seth M Cohen
Journal:  Bioorg Chem       Date:  2021-10-01       Impact factor: 5.275

3.  Baloxavir Treatment Delays Influenza B Virus Transmission in Ferrets and Results in Limited Generation of Drug-Resistant Variants.

Authors:  Philippe Noriel Q Pascua; Jeremy C Jones; Bindumadhav M Marathe; Patrick Seiler; William V Caufield; Burgess B Freeman; Richard J Webby; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2021-08-23       Impact factor: 5.191

4.  Swine H1N1 Influenza Virus Variants with Enhanced Polymerase Activity and HA Stability Promote Airborne Transmission in Ferrets.

Authors:  Meng Hu; Jeremy C Jones; Balaji Banoth; Chet Raj Ojha; Jeri Carol Crumpton; Lisa Kercher; Robert G Webster; Richard J Webby; Charles J Russell
Journal:  J Virol       Date:  2022-03-07       Impact factor: 6.549

5.  Primary Swine Respiratory Epithelial Cell Lines for the Efficient Isolation and Propagation of Influenza A Viruses.

Authors:  Victoria Meliopoulos; Sean Cherry; Nicholas Wohlgemuth; Rebekah Honce; Karen Barnard; Phillip Gauger; Todd Davis; Peter Shult; Colin Parrish; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

6.  Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility.

Authors:  Jeremy C Jones; Philippe Noriel Q Pascua; Thomas P Fabrizio; Bindumadhav M Marathe; Patrick Seiler; Subrata Barman; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-26       Impact factor: 11.205

7.  Multiple polymerase acidic (PA) I38X substitutions in influenza A(H1N1)pdm09 virus permit polymerase activity and cause reduced baloxavir inhibition.

Authors:  Jeremy C Jones; Philippe N Q Pascua; Walter N Harrington; Richard J Webby; Elena A Govorkova
Journal:  J Antimicrob Chemother       Date:  2021-03-12       Impact factor: 5.790

8.  Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.

Authors:  Leo Y Lee; Jie Zhou; Paulina Koszalka; Rebecca Frise; Rubaiyea Farrukee; Keiko Baba; Shahjahan Miah; Takao Shishido; Monica Galiano; Takashi Hashimoto; Shinya Omoto; Takeki Uehara; Edin J Mifsud; Neil Collinson; Klaus Kuhlbusch; Barry Clinch; Steffen Wildum; Wendy S Barclay; Aeron C Hurt
Journal:  PLoS Pathog       Date:  2021-05-06       Impact factor: 6.823

Review 9.  Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.

Authors:  Elena A Govorkova; Emi Takashita; Rod S Daniels; Seiichiro Fujisaki; Lance D Presser; Mira C Patel; Weijuan Huang; Angie Lackenby; Ha T Nguyen; Dmitriy Pereyaslov; Aine Rattigan; Sook Kwan Brown; Magdi Samaan; Kanta Subbarao; Sun Wong; Dayan Wang; Richard J Webby; Hui-Ling Yen; Wenqing Zhang; Adam Meijer; Larisa V Gubareva
Journal:  Antiviral Res       Date:  2022-03-12       Impact factor: 10.103

Review 10.  Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.

Authors:  Michael G Ison; Frederick G Hayden; Alan J Hay; Larisa V Gubareva; Elena A Govorkova; Emi Takashita; Jennifer L McKimm-Breschkin
Journal:  Antiviral Res       Date:  2021-08-04       Impact factor: 10.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.